Pfizer Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
輝瑞股票在公司公佈Q2業績超預期表現後上漲。
Pfizer Q2 2024 Adj. EPS $0.60 Beats $0.46 Estimate, Sales $13.283B Beat $13.024B Estimate
輝瑞2024年Q2調整後EPS爲0.60美元，超出0.46美元的預期，銷售額132.83億美元超過130.24億美元的預期
Pfizer Expects 2024 Sales Of $59.5B-$62.5B Compared To Prior Guidance Of $58.5B-$61.5B And Consensus Of $60.668B
輝瑞預計2024年銷售額爲595億美元。相比之前的指導585億美元和60.668億美元的共識，這是625億美元。